(Total Views: 288)
Posted On: 03/08/2017 4:41:11 PM
Post# of 72433
![Avatar](https://investorshangout.com/images/ProfileImages/398685088_3064_306524.png)
Re: rosalieone #31993
50% clinical remission is pretty good, considering the optimal dosage hasn't been determined yet.
The bar isn't set very high for approval. J&J's Remicade, the leader in the UC market with $2B in annual sales, had 39% of patients with clinical remission comparing to 15% in the placebo group.
http://www.remicadehcp.com/ulcerative-colitis...-remission
Then there are the side effects of biologics.
The bar isn't set very high for approval. J&J's Remicade, the leader in the UC market with $2B in annual sales, had 39% of patients with clinical remission comparing to 15% in the placebo group.
http://www.remicadehcp.com/ulcerative-colitis...-remission
Then there are the side effects of biologics.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)